These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23281184)

  • 21. Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases.
    Mouthuy N; Cosnard G; Abarca-Quinones J; Michoux N
    J Neuroradiol; 2012 Dec; 39(5):301-7. PubMed ID: 22197404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.
    Pichler J; Pachinger C; Pelz M; Kleiser R
    Eur J Radiol; 2013 May; 82(5):e240-5. PubMed ID: 23399039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
    Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
    Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of volumetric methods for tumor measurements on two and three dimensional MRI in adult glioblastoma.
    Wang MY; Cheng JL; Han YH; Li YL; Dou SW; Yan FS; Shi DP
    Neuroradiology; 2011 Aug; 53(8):565-9. PubMed ID: 21057780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simplified spin and gradient echo approach for brain tumor perfusion imaging.
    Stokes AM; Quarles CC
    Magn Reson Med; 2016 Jan; 75(1):356-62. PubMed ID: 25753958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wavelet-based reconstruction of dynamic susceptibility MR-perfusion: a new method to visualize hypervascular brain tumors.
    Huber T; Rotkopf L; Wiestler B; Kunz WG; Bette S; Gempt J; Preibisch C; Ricke J; Zimmer C; Kirschke JS; Sommer WH; Thierfelder KM
    Eur Radiol; 2019 May; 29(5):2669-2676. PubMed ID: 30552476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of tumor size in adult glioblastoma: classical cross-sectional criteria on 2D MRI or volumetric criteria on high resolution 3D MRI?
    Wang MY; Cheng JL; Han YH; Li YL; Dai JP; Shi DP
    Eur J Radiol; 2012 Sep; 81(9):2370-4. PubMed ID: 21652157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
    Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
    Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images.
    Blanchet L; Krooshof PW; Postma GJ; Idema AJ; Goraj B; Heerschap A; Buydens LM
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):67-73. PubMed ID: 21051512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
    Schmainda KM; Prah MA; Rand SD; Liu Y; Logan B; Muzi M; Rane SD; Da X; Yen YF; Kalpathy-Cramer J; Chenevert TL; Hoff B; Ross B; Cao Y; Aryal MP; Erickson B; Korfiatis P; Dondlinger T; Bell L; Hu L; Kinahan PE; Quarles CC
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
    Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
    J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
    J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting MGMT methylation status of glioblastomas from MRI texture.
    Levner I; Drabycz S; Roldan G; De Robles P; Cairncross JG; Mitchell R
    Med Image Comput Comput Assist Interv; 2009; 12(Pt 2):522-30. PubMed ID: 20426152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
    Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
    Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.